Johnson & Johnson (JNJ)CFO sold ~$6.06M
Joseph J Wolk, CFO at Johnson & Johnson, sold ~$6.06M of Johnson & Johnson shares.
- ~$6.06M
- Approx. value · 25K sh @ $242.68
- 14K
- Holds after · shares reported
- Traded
- Feb 17, 2026
- Filed
- Feb 19, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 20, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
- Nov 25, 2025Insider10% owner sold ~$160K of JNJ shares in the open market
- Nov 26, 2025Insider10% owner sold ~$64K of JNJ shares in the open market
- Dec 9, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Dec 16, 2025Federal contractDepartment of Veterans Affairs awarded Johnson & Johnson: $0 obligated to date
- Dec 18, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Jan 21, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 23, 2026CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
- Jan 26, 2026Insider · 1 personInsiders: 2 sales (~$22.1M)
- Feb 5, 20265% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
- Feb 11, 2026Federal contract · $280K obligatedDepartment of Defense awarded Johnson & Johnson: $280K obligated to date
- Feb 13, 2026Insider · 1 personInsiders: 2 sales (~$10.1M)
- Feb 17, 2026 · this disclosureInsider · Their largest sale since 2022CFO sold ~$6.06M of JNJ shares in the open market
What came next
- Feb 17, 2026Insider · 4 peopleInsiders: 8 sales (~$35.3M)
- Feb 18, 2026Insider · 1 personInsiders: 2 sales (~$5.5M)
- Feb 19, 2026Federal contract · $155K obligatedDepartment of Defense awarded Johnson & Johnson: $155K obligated to date
- Feb 20, 2026InsiderChair sold ~$325K of JNJ shares in the open market
- Feb 23, 2026Federal contract · $371K obligatedDepartment of Defense awarded Johnson & Johnson: $371K obligated to date
- Feb 26, 2026Federal contract · $272K obligatedDepartment of Defense awarded Johnson & Johnson: $272K obligated to date
- Feb 27, 2026InsiderOfficer sold ~$1.01M of JNJ shares in the open market
- Mar 4, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
- Mar 10, 2026CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Mar 16, 2026Federal contract · $205K obligatedDepartment of Defense awarded Johnson & Johnson: $205K obligated to date
- Mar 19, 2026Congress · 2 peopleMembers of Congress: 3 sales
- Mar 20, 2026Federal contract · $20K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $20K obligated to date
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 26, 2026CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Apr 14, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 28, 2026FDAFDA drug approval: Tremfya
- May 28, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Johnson & Johnson: $21K obligated to date
- Jun 11, 2026FDAFDA device clearance: MAXFRAME AUTOSTRUT with Bluetooth Multi-Axial Correction System
- Jun 11, 2026FDARecall: ABIOMED Impella CP Set, Pump Set Code 0048-0003, containing BIOMED Impella Introducer, 14 Fr, 13 cm & 25 cm, Product Code 0052-3046. heart pump and accessories
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 15 insider filings (SEC Form 4 or Form 144), 8 Congress trade reports, 167 fund holdings reports (13F) and 5 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
Other recent filings by Joseph J Wolk, Exec VP, CFO
- SEC Form 4 at Johnson & Johnson (JNJ)Feb 19, 2026
- SEC Form 4 at Johnson & Johnson (JNJ)Feb 19, 2026
- SEC Form 4 at Johnson & Johnson (JNJ)Feb 19, 2026
- SEC Form 4 at Prudential Financial (PRU)Feb 12, 2026
- SEC Form 4 at Johnson & Johnson (JNJ)Aug 18, 2025
The full history of Joseph J Wolk, Exec VP, CFO is on the profile page.
How this filing works
Other disclosures at Johnson & Johnson
- House Clerk periodic transaction reportOct 5, 2026
- USAspending.gov award recordOct 5, 2026
- USAspending.gov award recordSep 22, 2026
- USAspending.gov award recordSep 21, 2026
- House Clerk periodic transaction reportSep 12, 2026
- Senate eFD periodic transaction reportSep 11, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
